Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
392
-
Total 13F shares, excl. options
-
43M
-
Shares change
-
+61.1K
-
Total reported value, excl. options
-
$7.71B
-
Value change
-
+$18.7M
-
Put/Call ratio
-
0.53
-
Number of buys
-
159
-
Number of sells
-
-190
-
Price
-
$179.41
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2021
457 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2021.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 392 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43M shares
of 44.8M outstanding shares and own 96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.33M shares), VANGUARD GROUP INC (4.2M shares), RENAISSANCE TECHNOLOGIES LLC (3.11M shares), Avoro Capital Advisors LLC (3M shares), FMR LLC (2.35M shares), STATE STREET CORP (1.46M shares), ACADIAN ASSET MANAGEMENT LLC (799K shares), Bank of New York Mellon Corp (722K shares), GEODE CAPITAL MANAGEMENT, LLC (710K shares), and Palo Alto Investors LP (687K shares).
This table shows the top 392 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.